Evidence map›Paper›PMID 41840422›Full record

ReviewChinese medicine2026

Anti-cancer mechanism of traditional Chinese medicine natural products targeting ferroptosis.

Jiying Zhou, Peiying Lu, Meiling Guo, Xiaodong Chen, Keyan Chai, Haojia Wang, Lijia Zhou, Yiyan Zhai, Jiaqi Li, Chuanqi Qiao and 4 more

Abstract readReview
In one paragraph

Review in Chinese medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Jiying ZhouSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Peiying LuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Meiling GuoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Xiaodong ChenSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Keyan ChaiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Haojia WangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Lijia ZhouSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Yiyan ZhaiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Jiaqi LiSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Chuanqi QiaoSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Siyun YangSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China.
Hua LuoGuangxi University of Chinese Medicine, Nanning, 530001, China. hualuo@um.edu.mo.
Peizhi YeNational Cancer Center / National Clinical Research Center for Cancer, Chinese Medicine Department of the Cancer Hospital of the Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. xiaokaimen@126.com.
Jiarui WuSchool of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, 102488, China. exogamy@163.com.

Funding

Natural Science Foundation of Beijing Municipality No. 7242230
6 · The paper itself

Abstract

Ferroptosis is a novel iron-dependent form of programmed cell death characterized by the accumulation of lipid peroxides. Its mechanism involves the disruption of iron metabolism, imbalances in the antioxidant system, and lipid peroxidation. As a leading global cause of death, cancer treatment often faces challenges such as drug resistance and adverse side effects. Traditional Chinese medicine (TCM), as a complementary and alternative therapy, demonstrates significant potential in tumor treatment due to its multi-targeted and multi-pathway regulatory advantages. Recent studies reveal that numerous natural products in Chinese herbal medicines can inhibit tumor growth by inducing ferroptosis. This review systematically elucidates the core molecular mechanisms of ferroptosis, encompassing iron metabolism, lipid peroxidation, and various regulatory pathways. It highlights the research progress on how natural products from TCM induce ferroptosis by regulating key targets in lung cancer, breast cancer, colorectal cancer, gastric cancer, and liver cancer. This review aims to provide a reference for the development of anticancer drugs based on TCM.

Indexed as

Anti-tumorFerroptosisMechanismNatural productsTraditional Chinese medicine

Identifiers

PMID41840422
PMCPMC12990478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.